These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33619904)

  • 1. Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection.
    Hakomäki H; Kokki H; Lehtonen M; Ranta VP; Räsänen J; Voipio HM; Kokki M
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00726. PubMed ID: 33619904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational changes in buprenorphine exposure: A physiologically-based pharmacokinetic analysis.
    Zhang H; Kalluri HV; Bastian JR; Chen H; Alshabi A; Caritis SN; Venkataramanan R
    Br J Clin Pharmacol; 2018 Sep; 84(9):2075-2087. PubMed ID: 29873094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy.
    Bastian JR; Chen H; Zhang H; Rothenberger S; Tarter R; English D; Venkataramanan R; Caritis SN
    Am J Obstet Gynecol; 2017 Jan; 216(1):64.e1-64.e7. PubMed ID: 27687214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MATERNAL AND FETAL BUPRENORPHINE PHARMACOKINETICS IN PREGNANT SHEEP DURING TRANSDERMAL PATCH DOSING: Buprenorphine pharmacokinetics in pregnant sheep.
    Hakomäki H; Kokki H; Lehtonen M; Räsänen J; Voipio HM; Ranta VP; Kokki M
    Eur J Pharm Sci; 2021 Oct; 165():105936. PubMed ID: 34273481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evidence-based recommendation to increase the dosing frequency of buprenorphine during pregnancy.
    Caritis SN; Bastian JR; Zhang H; Kalluri H; English D; England M; Bobby S; Venkataramanan R
    Am J Obstet Gynecol; 2017 Oct; 217(4):459.e1-459.e6. PubMed ID: 28669739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Evaluation of Once-Weekly and Once-Monthly Buprenorphine Subcutaneous Injection Depots (CAM2038) Versus Intravenous and Sublingual Buprenorphine in Healthy Volunteers Under Naltrexone Blockade: An Open-Label Phase 1 Study.
    Albayaty M; Linden M; Olsson H; Johnsson M; Strandgården K; Tiberg F
    Adv Ther; 2017 Feb; 34(2):560-575. PubMed ID: 28070862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy Alters CYP- and UGT-Mediated Metabolism of Buprenorphine.
    Zhang H; Bastian JR; Zhao W; Chen H; Shaik IH; Chaphekar N; Caritis SN; Venkataramanan R
    Ther Drug Monit; 2020 Apr; 42(2):264-270. PubMed ID: 31929398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women.
    Concheiro M; Jones HE; Johnson RE; Choo R; Huestis MA
    Ther Drug Monit; 2011 Oct; 33(5):619-26. PubMed ID: 21860340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of buprenorphine after intravenous administration in the mouse.
    Yu S; Zhang X; Sun Y; Peng Y; Johnson J; Mandrell T; Shukla AJ; Laizure SC
    J Am Assoc Lab Anim Sci; 2006 May; 45(3):12-6. PubMed ID: 16642964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine for the treatment of opioid dependence in pregnancy.
    Mittal L
    J Perinat Neonatal Nurs; 2014; 28(3):178-84. PubMed ID: 25062519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system distribution of buprenorphine in pregnant sheep, fetuses and newborn lambs after continuous transdermal and single subcutaneous extended-release dosing.
    Hakomäki H; Eskola S; Kokki H; Lehtonen M; Räsänen J; Laaksonen S; Voipio HM; Ranta VP; Kokki M
    Eur J Pharm Sci; 2022 Nov; 178():106283. PubMed ID: 36029997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of a buprenorphine subcutaneous depot formulation (CAM2038) for once-weekly dosing in patients with opioid use disorder.
    Haasen C; Linden M; Tiberg F
    J Subst Abuse Treat; 2017 Jul; 78():22-29. PubMed ID: 28554599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Kratom, an Opioid-like Traditional Herb, in Pregnancy.
    Smid MC; Charles JE; Gordon AJ; Wright TE
    Obstet Gynecol; 2018 Oct; 132(4):926-928. PubMed ID: 30204686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine.
    Gopal S; Tzeng TB; Cowan A
    Eur J Pharm Sci; 2002 Apr; 15(3):287-93. PubMed ID: 11923061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States.
    Lo-Ciganic WH; Donohue JM; Kim JY; Krans EE; Jones BL; Kelley D; James AE; Jarlenski MP
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):80-89. PubMed ID: 30192041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment.
    Ilett KF; Hackett LP; Gower S; Doherty DA; Hamilton D; Bartu AE
    Breastfeed Med; 2012 Aug; 7():269-74. PubMed ID: 22011128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine implants (Probuphine) for opioid dependence.
    Med Lett Drugs Ther; 2016 Jul; 58(1499):94-5. PubMed ID: 27403784
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans.
    Huestis MA; Cone EJ; Pirnay SO; Umbricht A; Preston KL
    Drug Alcohol Depend; 2013 Aug; 131(3):258-62. PubMed ID: 23246635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder.
    Walsh SL; Comer SD; Zdovc JA; Sarr C; Björnsson M; Strandgården K; Hjelmström P; Tiberg F
    Neuropsychopharmacology; 2024 May; 49(6):1050-1057. PubMed ID: 38200140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients.
    McCance-Katz EF; Moody DE; Prathikanti S; Friedland G; Rainey PM
    Drug Alcohol Depend; 2011 Nov; 118(2-3):326-34. PubMed ID: 21596492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.